These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 16584109

  • 21. Leucocyte antibodies in blood donors and a look back on recipients of their blood components.
    Maślanka K, Michur H, Zupańska B, Uhrynowska M, Nowak J.
    Vox Sang; 2007 Apr; 92(3):247-9. PubMed ID: 17348874
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Alloexposed blood donors and transfusion-related acute lung injury: a case-referent study.
    Middelburg RA, van Stein D, Atsma F, Wiersum-Osselton JC, Porcelijn L, Beckers EA, Briët E, van der Bom JG.
    Transfusion; 2011 Oct; 51(10):2111-7. PubMed ID: 21985044
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury.
    ISBT Working Party on Granulocyte ImmunobiologyPlatelet and Leucocyte Immunology Laboratory, EFS Ile de France, Hopital Henri Mondor, Creteil, France., Bierling P, Bux J, Curtis B, Flesch B, Fung L, Lucas G, Macek M, Muniz-Diaz E, Porcelijn L, Reil A, Sachs U, Schuller R, Tsuno N, Uhrynowska M, Urbaniak S, Valentin N, Wikman A, Zupanska B.
    Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164
    [Abstract] [Full Text] [Related]

  • 29. TRALI risk reduction: donor and component management strategies.
    Eder AF, Benjamin RJ.
    J Clin Apher; 2009 Apr; 24(3):122-9. PubMed ID: 19365816
    [Abstract] [Full Text] [Related]

  • 30. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
    Lucas G, Win N, Calvert A, Green A, Griffin E, Bendukidze N, Hopkins M, Browne T, Poles A, Chapman C, Massey E.
    Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
    [Abstract] [Full Text] [Related]

  • 31. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
    Kleinman S, Grossman B, Kopko P.
    Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
    [Abstract] [Full Text] [Related]

  • 32. Allo-exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI.
    Middelburg RA, Beckers EA, Porcelijn L, Lardy N, Wiersum-Osselton JC, Schipperus MR, Vrielink H, Briët E, van der Bom JG.
    Transfus Med; 2012 Apr; 22(2):128-32. PubMed ID: 22380759
    [Abstract] [Full Text] [Related]

  • 33. Are we underestimating reverse TRALI?
    De Clippel D, Emonds MP, Compernolle V.
    Transfusion; 2019 Sep; 59(9):2788-2793. PubMed ID: 31241780
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Transfusion-related acute lung injury (TRALI) in graft by blood donor antibodies against host leukocytes.
    Goodwin J, Tinckam K, denHollander N, Haroon A, Keshavjee S, Cserti-Gazdewich CM.
    J Heart Lung Transplant; 2010 Sep; 29(9):1067-70. PubMed ID: 20627626
    [Abstract] [Full Text] [Related]

  • 36. Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report.
    Porretti L, Coluccio E, Prati D, Colombo MB, Lopa R, Tombolini P, Ambrosone A, Crespiatico L, Scalamogna M, Rebulla P.
    Eur J Haematol; 2004 Oct; 73(4):295-9. PubMed ID: 15347317
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Transfusion-related acute lung injury during plasma exchange: Suspecting the unsuspected.
    Askari S, Nollet K, Debol SM, Brunstein CG, Eastlund T.
    J Clin Apher; 2002 Oct; 17(2):93-6. PubMed ID: 12210713
    [Abstract] [Full Text] [Related]

  • 39. Implementation of a strategy to prevent TRALI in a regional blood centre.
    Insunza A, Romon I, Gonzalez-Ponte ML, Hoyos A, Pastor JM, Iriondo A, Hermosa V.
    Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
    [Abstract] [Full Text] [Related]

  • 40. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
    Sachs UJ, Kauschat D, Bein G.
    Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.